BRCA2 and posterior cortical atrophy: Deleterious germline mutations in BRCA2 are known genetic events that confer increasing risk for patients with PCa [4, 5] and a germline BRCA2 mutation is an independent prognostic factor for early-onset phenotype, aggressive disease, and poor clinical outcomes [4, 6, 7].